Adjuvant Systemic Therapy in Melanoma: Relative Versus Absolute Benefit; the Number Needed to Treat (NNT) Versus the Number Needed to Harm (NNH)?
EJC Skin Cancer（2024）
关键词
Melanoma,Adjuvant,Immunotherapy,BRAF,Targeted therapy,Number needed to treat,Harm, Cost-effectiveness,Surgery, Stage III
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要